Company:  TAKEDA PHARMACEUTICAL CO ... (TAK)
Form Type:  424B3
Filing Date:  11/14/2019 
CIK:  0001395064 
Address:  1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU 
City, State, Zip:  TOKYO,  103-8668 
Telephone:  81332782111 
Last Trade
Last Trade: 
$20.23  
Change: 
-0.09 (-0.44%)  
Trade Time: 
Dec 13  
Market Cap: 
$63.78B
Trade TAK now with 

© 2019  
Description of Business
We are a global, research and development-driven pharmaceutical company with a presence in more than 70 countries. We bring highly-innovative, life-changing medicines to patients across the globe, with prescription drugs marketed directly or through our partners in approximately 100 countries worldwide. Our global workforce of more than 27,000 employees is committed to bringing better health and a brighter future to patients. We develop and market pharmaceutical products to treat a broad range of medical conditions including GI diseases, cancer, neurological and psychiatric diseases and other medical conditions, including diabetes and hypertension, as well as vaccines. We are also committed to our corporate social responsibility program, which is dedicated to global health, and our access to medicine strategy, which aims to increase access to innovative and potentially life-saving medicines for patients with some of the highest unmet medical needs across the world.
Register and access this filing in:     
  FORM 424B3
    TABLE OF CONTENTS
    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
    WHERE YOU CAN FIND MORE INFORMATION
    ENFORCEABILITY OF CIVIL LIABILITIES
    PROSPECTUS SUMMARY
    RISK FACTORS
      BALANCE SHEET
    USE OF PROCEEDS
    CAPITALIZATION
    SELECTED CONSOLIDATED FINANCIAL AND OPERATING DATA
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
      Liquidity and Capital Resources.
        CASH FLOW
    BUSINESS
      Competition
    OUR MANAGEMENT
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
    PRINCIPAL SHAREHOLDERS
      BENEFICIAL OWNERS
    RELATED PARTY TRANSACTIONS
    THE EXCHANGE OFFER
      BENEFICIAL OWNERS
    DESCRIPTION OF THE EXCHANGE NOTES
    TAXATION
    PLAN OF DISTRIBUTION
      BENEFICIAL OWNERS
      INFORMATION AND EXCHANGE AGENT
    VALIDITY OF THE NOTES
    EXPERTS
    INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND OTHER ...
      Report of Independent Registered Public Accounting Firm
        INCOME STATEMENT
        INCOME STATEMENT
        BALANCE SHEET
        CASH FLOW
        BALANCE SHEET
        BALANCE SHEET
        BALANCE SHEET
      INDEPENDENT AUDITORS' REPORT
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
      NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        INCOME STATEMENT
        INCOME STATEMENT
        INCOME STATEMENT
        INCOME STATEMENT
      6 Other Operating Expenses